公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1997 | Acute viral hepatitis in alien residents in Taiwan: A hospital-based study | Yang S.-S.; Lai Y.-C.; Wu, C.-H.; Chen, T.-K.; Lee, C.-L.; DING-SHINN CHEN | Gastroenterological Journal of Taiwan | |||
2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | CHUN-JEN LIU ; Chang J.; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Yang M.-D.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | World Journal of Gastroenterology | 54 | 51 | |
2015 | Asunaprevir-containing regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 6 | 5 | |
2013 | Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients | Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO ; Yang S.-S.; DING-SHINN CHEN | Antiviral Therapy | 8 | 8 | |
2006 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C | Yang S.-S.; Fu L.-S.; Chang C.-S.; Yeh H.-Z.; Chen G.-H.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 17 | 17 | |
1996 | Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis | Yang S.-S.; Tsai G.; Wu C.-H.; DING-SHINN CHEN | Hepato-Gastroenterology | |||
2011 | Classification of PICO elements by text features systematically extracted from PubMed abstracts | Huang K.-C.; Liu C.C.-H.; Yang S.-S.; FU-REN XIAO ; Wong J.-M.; Liao C.-C.; Chiang I.-J. | Proceedings - 2011 IEEE International Conference on Granular Computing, GrC 2011 | 17 | 0 | |
2003 | Combination of interferon alfa-2a and amantadine does not improve the efficacy of interferon therapy in patients with chronic hepatitis C | Yang S.-S.; Tu T.-C.; Wu C.-H.; DING-SHINN CHEN | Hepato-Gastroenterology | |||
2016 | Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Hepatology International | 8 | 8 | |
2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; DING-SHINN CHEN | Journal of the National Cancer Institute | 496 | 408 | |
2002 | Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B | Yang S.-S.; Cheng K.-S.; Lai Y.-C.; Wu C.-H.; Chen T.-K.; Lee C.-L.; DING-SHINN CHEN | Journal of Gastroenterology | 49 | 41 | |
2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 39 | 38 | |
2006 | Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients | CHIEN-HUNG CHEN ; Chang T.-T.; Cheng K.-S.; Su W.-W.; Yang S.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Liver International | 63 | 56 | |
1995 | Early interferon therapy and abortion of posttransfusion hepatitis C viral infection | Yang S.-S.; Wu C.-H.; Huang, C.-S.; Ho, M.-S.; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Clinical Gastroenterology | |||
2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | TAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 76 | 70 | |
2016 | Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan | Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; TUNG-HUNG SU ; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO | Hepatology International | 3 | 3 | |
2002 | Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection | Tai D.-I.; CHIEN-HUNG CHEN ; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; Liaw Y.-F.; DING-SHINN CHEN ; Sung J.-L. | Journal of Gastroenterology and Hepatology (Australia) | 25 | 21 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 9 | 6 | |
2010 | Esophagogastric varices predict mortality in hospitalized patients with alcoholic liver disease in Taiwan | Lin C.-W. ; Chen Y.-S.; Lai C.-H.; Perng D.-S.; Weng H.-C.; Hu J.-T.; YI-WEN HUANG ; Hsu M.-Y.; Yang S.-S. | Hepato-Gastroenterology | |||
2022 | Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals | Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators | Viruses | 2 | 1 |